The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.
But not every company with momentum is a long-term winner, and plenty of investors have lost money betting on short-term fads. All that said, here are three overhyped stocks that may correct and some you should consider instead.
Biogen (BIIB)
One-Month Return: +3.7%
Founded in 1978 and pioneering treatments for some of medicine’s most complex challenges, Biogen (NASDAQ:BIIB) develops and markets therapies for neurological conditions, including multiple sclerosis, Alzheimer’s disease, spinal muscular atrophy, and rare diseases.
Why Is BIIB Not Exciting?
- Annual sales declines of 4.6% for the past five years show its products and services struggled to connect with the market during this cycle
- Sales were less profitable over the last five years as its earnings per share fell by 11.4% annually, worse than its revenue declines
- Diminishing returns on capital suggest its earlier profit pools are drying up
At $200 per share, Biogen trades at 14.8x forward P/E. Dive into our free research report to see why there are better opportunities than BIIB.
TriCo Bancshares (TCBK)
One-Month Return: +7.9%
Founded in 1975 and headquartered in Chico, California, TriCo Bancshares (NASDAQ:TCBK) operates Tri Counties Bank, providing personal, small business, and commercial banking services through branches across California.
Why Are We Hesitant About TCBK?
- Net interest income trends were unexciting over the last five years as its 6.6% annual growth was below the typical banking firm
- Earnings per share lagged its peers over the last five years as they only grew by 7.4% annually
- Estimated tangible book value per share growth of 8.9% for the next 12 months implies profitability will slow from its two-year trend
TriCo Bancshares’s stock price of $52.66 implies a valuation ratio of 1.2x forward P/B. To fully understand why you should be careful with TCBK, check out our full research report (it’s free).
Republic Bancorp (RBCAA)
One-Month Return: +16.3%
With roots dating back to 1974 and operating across multiple states including Kentucky, Indiana, Florida, Ohio, and Tennessee, Republic Bancorp (NASDAQGS:RBCA.A) is a Kentucky-based financial holding company that operates a bank offering traditional banking, mortgage services, and specialized financial products.
Why Do We Think Twice About RBCAA?
- Net interest income trends were unexciting over the last five years as its 5.4% annual growth was below the typical banking firm
- Estimated net interest income growth of 3.9% for the next 12 months implies demand will slow from its five-year trend
- Estimated tangible book value per share growth of 8% for the next 12 months implies profitability will slow from its two-year trend
Republic Bancorp is trading at $87.79 per share, or 1.4x forward P/B. Check out our free in-depth research report to learn more about why RBCAA doesn’t pass our bar.
High-Quality Stocks for All Market Conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
